Skip to main content

Nektar Therapeutics

NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000906709

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 3 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Nektar Therapeutics as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
+13 vs. Q1 2024
Shares held
135.5M
+22.5M (+19.9%) vs. Q1 2024
Total value
$168.0M
+$62.4M (+59.2%) vs. Q1 2024
New holders
36
36 more added
Sold out
23
35 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 135 institutions
Q1 2021: 239 institutionsQ2 2021: 243 institutionsQ3 2021: 243 institutionsQ4 2021: 242 institutionsQ1 2022: 243 institutionsQ2 2022: 230 institutionsQ3 2022: 232 institutionsQ4 2022: 217 institutionsQ1 2023: 197 institutionsQ2 2023: 148 institutionsQ3 2023: 139 institutionsQ4 2023: 127 institutionsQ1 2024: 123 institutionsQ2 2024: 135 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 157 institutionsQ2 2025: 109 institutionsQ3 2025: 153 institutionsQ4 2025: 180 institutionsQ1 2026: 216 institutionsQ2 2026: 239 institutions
Value heldQ2 2024: $168.0M
Q1 2021: $3.40BQ2 2021: $2.89BQ3 2021: $3.01BQ4 2021: $2.35BQ1 2022: $947.6MQ2 2022: $693.8MQ3 2022: $561.4MQ4 2022: $381.7MQ1 2023: $121.2MQ2 2023: $79.3MQ3 2023: $85.3MQ4 2023: $67.3MQ1 2024: $105.5MQ2 2024: $168.0MQ3 2024: $182.9MQ4 2024: $123.6MQ1 2025: $84.2MQ2 2025: $197.7MQ3 2025: $820.2MQ4 2025: $732.2MQ1 2026: $1.94BQ2 2026: $2.50B
Institutions holding NKTR and their total value by quarter
QuarterHoldersValue
Q2 2026239$2.50B
Q1 2026216$1.94B
Q4 2025180$732.2M
Q3 2025153$820.2M
Q2 2025109$197.7M
Q1 2025157$84.2M
Q4 2024146$123.6M
Q3 2024140$182.9M
Q2 2024135$168.0M
Q1 2024123$105.5M
Q4 2023127$67.3M
Q3 2023139$85.3M
Q2 2023148$79.3M
Q1 2023197$121.2M
Q4 2022217$381.7M
Q3 2022232$561.4M
Q2 2022230$693.8M
Q1 2022243$947.6M
Q4 2021242$2.35B
Q3 2021243$3.01B
Q2 2021243$2.89B
Q1 2021239$3.40B

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q1 2024.

Institutions holding NKTR in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Northern Trust Corp449,750$557.7K0.00%+90,608+25.2%Added
Dimensional Fund Advisors LP515,998$639.1K0.00%−27,764−5.1%Reduced
Bank of New York Mellon Corp551,535$683.9K0.00%+532,663+2,822.5%Added
Connor, Clark & Lunn Investment Management Ltd.616,242$764.1K0.00%+42,193+7.4%Added
Woodline Partners LP622,905$772.4K0.01%+622,905New
Invesco Ltd.644,226$798.8K0.00%+117,883+22.4%Added
CM Management, LLC750,000$930.0K0.85%−189,847−20.2%Reduced
Armistice Capital, LLC836,000$1.04M0.03%+836,000New
Acuitas Investments, LLC879,904$1.09M0.58%−400,700−31.3%Reduced
Almitas Capital LLC920,225$1.14M0.47%00.0%Unchanged
Gsa Capital Partners LLP930,943$1.15M0.08%−1,058,962−53.2%Reduced
UBS Oconnor LLC1,043,930$1.29M0.04%+108,310+11.6%Added
Ikarian Capital, LLC1,312,405$1.63M0.51%+1,312,405New
Morgan Stanley1,472,631$1.83M0.00%+1,303,831+772.4%Added
Charles Schwab Investment Management Inc1,487,730$1.84M0.00%+359,411+31.9%Added
Goldman Sachs Group Inc1,767,495$2.19M0.00%+1,057,189+148.8%Added
Two Sigma Investments, LP1,809,180$2.24M0.01%−272,760−13.1%Reduced
Two Sigma Advisers, LP1,835,742$2.28M0.01%−404,600−18.1%Reduced
Shay Capital LLC1,840,377$2.28M0.64%−239,297−11.5%Reduced
Monaco Asset Management SAM2,166,432$2.69M1.34%−3,665,133−62.8%Reduced
Jacobs Levy Equity Management, Inc2,873,192$3.56M0.01%+962,006+50.3%Added
State Street Corp2,989,974$3.71M0.00%+2,298,148+332.2%Added
Renaissance Technologies LLC3,313,833$4.11M0.01%−1,306,848−28.3%Reduced
TCG Crossover Management, LLC4,000,000$4.96M0.52%00.0%Unchanged
Nantahala Capital Management, LLC4,110,000$5.10M0.51%+1,634,046+66.0%Added
Geode Capital Management, LLC4,112,499$5.10M0.00%+2,059,414+100.3%Added
Millennium Management LLC4,659,469$5.78M0.00%+1,674,924+56.1%Added
Acadian Asset Management LLC4,884,594$6.05M0.02%−2,684,469−35.5%Reduced
Primecap Management Co6,020,453$7.47M0.01%−946,194−13.6%Reduced
Citadel Advisors LLC6,954,970$8.62M0.01%+3,761,256+117.8%Added
Eventide Asset Management, LLC7,529,096$9.34M0.16%+7,529,096New
Samlyn Capital, LLC9,457,887$11.7M0.20%+9,457,887New
Vanguard Group Inc12,967,498$16.1M0.00%+918,360+7.6%Added
BlackRock Inc.15,155,673$18.8M0.00%+9,277,380+157.8%Added
Deep Track Capital, LP17,875,498$22.2M0.66%−524,502−2.9%Reduced
Stonepine Capital Management, LLC0$00.00%−3,480,409−100.0%Sold out
Lynx1 Capital Management LP0$00.00%−2,068,842−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−1,687,300−100.0%Sold out
Marshall Wace, LLP0$00.00%−1,471,237−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−1,069,272−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−535,800−100.0%Sold out
AQR Capital Management LLC0$00.00%−430,983−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−127,564−100.0%Sold out
Diversified Trust Co0$00.00%−60,211−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−60,064−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−67,437−100.0%Sold out
Squarepoint Ops LLC0$00.00%−38,781−100.0%Sold out
Lido Advisors, LLC0$00.00%−30,660−100.0%Sold out
Algert Global LLC0$00.00%−29,430−100.0%Sold out
SEI Investments Co0$00.00%−23,000−100.0%Sold out
First Citizens Bank & Trust Co0$00.00%−11,686−100.0%Sold out
Envestnet Portfolio Solutions, Inc.0$00.00%−11,686−100.0%Sold out
GTS Securities LLC0$00.00%−11,388−100.0%Sold out
First Manhattan Co0$00.00%−500−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−200−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−40−100.0%Sold out
Assetmark, Inc0$00.00%−22−100.0%Sold out
CWM, LLC0$00.00%−250−100.0%Sold out
Cutler Group LP––––Not filed